Amneal Pharmaceuticals, Inc. (AMRX)
17.54
-0.47
(-2.61%)
USD |
NASDAQ |
Aug 28, 16:00
17.53
-0.01
(-0.06%)
After-Hours: 20:00
Amneal Pharmaceuticals Cash and Short Term Investments (Quarterly) : 136.28M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 136.28M |
| March 31, 2026 | 201.83M |
| December 31, 2025 | 310.87M |
| September 30, 2025 | 235.98M |
| June 30, 2025 | 81.19M |
| March 31, 2025 | 65.77M |
| December 31, 2024 | 118.42M |
| September 30, 2024 | 78.34M |
| June 30, 2024 | 49.62M |
| March 31, 2024 | 51.62M |
| December 31, 2023 | 99.11M |
| September 30, 2023 | 95.61M |
| June 30, 2023 | 114.58M |
| March 31, 2023 | 151.07M |
| December 31, 2022 | 35.23M |
| September 30, 2022 | 95.89M |
| June 30, 2022 | 98.18M |
| March 31, 2022 | 216.54M |
| December 31, 2021 | 256.74M |
| September 30, 2021 | 310.62M |
| June 30, 2021 | 283.15M |
| March 31, 2021 | 455.81M |
| December 31, 2020 | 347.12M |
| September 30, 2020 | 283.65M |
| June 30, 2020 | 268.27M |
| Date | Value |
|---|---|
| March 31, 2020 | 406.92M |
| December 31, 2019 | 152.82M |
| September 30, 2019 | 217.06M |
| June 30, 2019 | 57.02M |
| March 31, 2019 | 66.74M |
| December 31, 2018 | 218.78M |
| September 30, 2018 | 172.19M |
| June 30, 2018 | 68.59M |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 77.92M |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | 157.25M |
| December 31, 2016 | 180.13M |
| September 30, 2016 | 232.12M |
| June 30, 2016 | 366.85M |
| March 31, 2016 | 412.18M |
| December 31, 2015 | 340.35M |
| September 30, 2015 | 318.40M |
| June 30, 2015 | 190.29M |
| March 31, 2015 | 163.09M |
| December 31, 2014 | 414.86M |
| September 30, 2014 | 442.52M |
| June 30, 2014 | 413.03M |
| March 31, 2014 | 390.43M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Liquidia Corp. | 284.18M |
| Eli Lilly & Co. | 8.95B |
| Viatris, Inc. | 1.410B |
| Pfizer Inc. | 11.70B |
| Indivior Pharmaceuticals, Inc. | 222.00M |